114 related articles for article (PubMed ID: 32202017)
41. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
42. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
43. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
[TBL] [Abstract][Full Text] [Related]
44. Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.
Daire JL; Leporq B; Vilgrain V; Van Beers BE; Schmidt S; Pastor CM
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):657-667. PubMed ID: 27778300
[TBL] [Abstract][Full Text] [Related]
45. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
Yrjänä SK; Vaara T; Karttunen A; Koivukangas J
Invest Radiol; 2008 Apr; 43(4):267-75. PubMed ID: 18340251
[TBL] [Abstract][Full Text] [Related]
46. Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
Gu K; Jeon TY; Yoo SY; Kim JH
Eur Radiol; 2021 Jan; 31(1):283-291. PubMed ID: 32797310
[TBL] [Abstract][Full Text] [Related]
47. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.
Schmitz SA; Mühler A; Wagner S; Wolf KJ
Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423
[TBL] [Abstract][Full Text] [Related]
48. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Wang QJ; Wang Y; Xu X; Xiao H; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
[TBL] [Abstract][Full Text] [Related]
49. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
Pediconi F; Fraioli F; Catalano C; Napoli A; Danti M; Francone M; Venditti F; Nardis P; Passariello R
Radiol Med; 2003; 106(1-2):87-93. PubMed ID: 12951555
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
[TBL] [Abstract][Full Text] [Related]
51. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
Bueltmann E; Erb G; Kirchin MA; Klose U; Naegele T
Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
[TBL] [Abstract][Full Text] [Related]
52. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
[TBL] [Abstract][Full Text] [Related]
53. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
[TBL] [Abstract][Full Text] [Related]
54. Clinical late phase II trials of MultiHance (Gd-BOPTA) for the magnetic resonance imaging of liver tumors in Japan.
Kuwatsuru R; Kadoya M; Ohtomo K; Tanimoto A; Hirohashi S; Murakami T; Tanaka Y; Yoshikawa K; Katayama H
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S65-74. PubMed ID: 10608400
[TBL] [Abstract][Full Text] [Related]
55. Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study.
Messina C; Albano D; Orlandi D; Chianca V; Corazza A; Ferrari F; Gitto S; Sconfienza LM
BMC Med Imaging; 2019 Oct; 19(1):83. PubMed ID: 31653206
[TBL] [Abstract][Full Text] [Related]
56. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging.
Channual S; Pahwa A; Lu DS; Raman SS
Abdom Radiol (NY); 2016 Sep; 41(9):1825-41. PubMed ID: 27225503
[TBL] [Abstract][Full Text] [Related]
57. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
58. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.
Pintaske J; Martirosian P; Graf H; Erb G; Lodemann KP; Claussen CD; Schick F
Invest Radiol; 2006 Mar; 41(3):213-21. PubMed ID: 16481903
[TBL] [Abstract][Full Text] [Related]
59. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI.
Wendland MF; Saeed M; Lauerma K; Derugin N; Mintorovitch J; Cavagna FM; Higgins CB
Magn Reson Med; 1997 Mar; 37(3):448-56. PubMed ID: 9055236
[TBL] [Abstract][Full Text] [Related]
60. Kinetics of the exchange reactions between Gd(DTPA)2-, Gd(BOPTA)2-, and Gd(DTPA-BMA) complexes, used as MRI contrast agents, and the triethylenetetraamine-hexaacetate ligand.
Pálinkás Z; Baranyai Z; Brücher E; Rózsa B
Inorg Chem; 2011 Apr; 50(8):3471-8. PubMed ID: 21405037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
